Close
RNS Number : 7167D
Provident Financial PLC
27 June 2019
 

Provident Financial plc ("the Company")

Director/PDMR Transaction - Initial Notification

 

The Company announces that it was notified on 25 June 2019 of the following transactions in the Company's Ordinary Shares of 20 8/11p undertaken by directors / persons discharging managerial responsibility ('PDMRs').

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

David Rutherford

 

2

 

Reason for the notification

 

a)

 

Position/status

 

PDMR

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Provident Financial plc

b)

 

LEI

 

213800U93SZC44VXN635

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 20 8/11p

 

GB00B1Z4ST84

 

b)

 

Nature of the transaction

 

 

Market purchase of 4,865 Ordinary Shares.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£4.02

4,865

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A (Single transaction)

e)

 

Date of the transaction

25 June 2019

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

Name of authorised official of issuer responsible for making notification:

David Whincup, Deputy Company Secretary

Date of Notification:

27 June 2019


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFFEREIDFIA